$240 Million Private Placement Announced By This Medical Company

Immunic, Inc. Announces a Monumental Private Placement of up to $240 Million.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

The biopharmaceutical sector is buzzing with the latest news from Immunic, Inc. (NASDAQ: IMUX), a clinical-stage biopharmaceutical company that specializes in developing oral therapies for chronic inflammatory…